Use of compounds having combined dopamine d2, 5-ht1a and...

Details Use of compounds having combined dopamine d2, 5-ht1a and... Use of compounds having combined dopamine d2, 5-ht1a and...

A - Human Necessities

61

K

A61K 31/428 (2006.01) A61K 31/00 (2006.01) A61K 31/4184 (2006.01) A61K 31/423 (2006.01) A61K 45/00 (2006.01) A61P 25/00 (2006.01) A61P 25/14 (2006.01) A61P 25/16 (2006.01) A61P 25/28 (2006.01) A61P 43/00 (2006.01) C07D 413/12 (2006.01)

Patent

CA 2405758

The invention relates to the use of compounds having combined sopamine D2 agonistic activity, 5-HT1A agonistic activity and a adrenoceptor agonistic activity for the treatment of CNS disorders such as Parkinson's disease.

L'invention concerne des composés présentant une combinaison de l'activité agoniste de la dopamine D2, de l'activité agoniste du 5-HT1A et de l'activité agoniste du récepteur adrénergique alpha, pour le traitement de troubles du système nerveux central, tels que la maladie de Parkinson.

Affiliated with

Also associated with

Rating

Use of compounds having combined dopamine d2, 5-ht1a and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of compounds having combined dopamine d2, 5-ht1a and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of compounds having combined dopamine d2, 5-ht1a and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1518236